Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Patent (4)
- Licensing (2)
- Trademarks (2)
- America invents (1)
- Ancillary (1)
-
- Apple (1)
- BCPIA (1)
- Biologic (1)
- Biopharmaceutical (1)
- Blurring (1)
- Brand equity (1)
- CCPA (1)
- Canada (1)
- Clinical data (1)
- Convergence (1)
- DMCA (1)
- DNA (1)
- Design patent (1)
- Diagnostic (1)
- Diffusion (1)
- Disclosure (1)
- Drug repurposing (1)
- FRAND licensing (1)
- FTAA (1)
- Growth theory (1)
- Human rights (1)
- ICANN (1)
- IPR strength (1)
- India (1)
- Indigenous people (1)
Articles 1 - 27 of 27
Full-Text Articles in Law
A New Framework For Assessing Clinical Data Transparency Initiatives, Erika Lietzan
A New Framework For Assessing Clinical Data Transparency Initiatives, Erika Lietzan
Marquette Intellectual Property Law Review
None.
Diagnostic Patents At The Supreme Court, Arti K. Rai
Diagnostic Patents At The Supreme Court, Arti K. Rai
Marquette Intellectual Property Law Review
None.
Ancillary Orders Of Compulsory Licensing And Their Compatibility With The Trips Agreement, Richard Li-Dar Wang
Ancillary Orders Of Compulsory Licensing And Their Compatibility With The Trips Agreement, Richard Li-Dar Wang
Marquette Intellectual Property Law Review
None.
The New Era Of Biologic Regulation And Patenting Under The America Invents Act, David I. Rucker
The New Era Of Biologic Regulation And Patenting Under The America Invents Act, David I. Rucker
Marquette Intellectual Property Law Review
None.
Repurposing - Finding New Uses For Old (And Patented) Drugs: Bridging The "Valley Of Death," To Translate Academic Research Into New Medicines, Daniel S. Sem
Marquette Intellectual Property Law Review
None.
Trademarks Under The North American Free Trade Agreement (Nafta), With References To The Current Mexican Law, Roberto Rosas
Trademarks Under The North American Free Trade Agreement (Nafta), With References To The Current Mexican Law, Roberto Rosas
Marquette Intellectual Property Law Review
None.
Territoriality Challenges In Protecting Trademark Interests In The System Of Generic Top-Level Domains (Gtlds), Jesse Kim
Marquette Intellectual Property Law Review
None.
How Media Got The Biggest Bite Of (The) Apple: A Look At The Media Misperception In The Apple-Samsung Case, Neha Pathak
How Media Got The Biggest Bite Of (The) Apple: A Look At The Media Misperception In The Apple-Samsung Case, Neha Pathak
Marquette Intellectual Property Law Review
None.
Ip Policy Forum: Drug Development - Translating Basic Research Into New Medicines - And This Issue Of Iplr, Tommy Thompson
Ip Policy Forum: Drug Development - Translating Basic Research Into New Medicines - And This Issue Of Iplr, Tommy Thompson
Marquette Intellectual Property Law Review
None.
Ip Policy Forum: Forward-Looking View Of Healthcare Innovation, From A Leading Life Science Venture Capitalist, G. Steven Burrill
Ip Policy Forum: Forward-Looking View Of Healthcare Innovation, From A Leading Life Science Venture Capitalist, G. Steven Burrill
Marquette Intellectual Property Law Review
None.
Ip Policy Forum: The Increasing Importance Of Biologics-Based Drugs In Pharmaceutical Pipelines, David Meininger
Ip Policy Forum: The Increasing Importance Of Biologics-Based Drugs In Pharmaceutical Pipelines, David Meininger
Marquette Intellectual Property Law Review
None.
Ip Policy Forum: Need For New Ip Approaches To Facilitate Collaborative (Academic-Industrial) Drug Development, Garret A. Fitzgerald
Ip Policy Forum: Need For New Ip Approaches To Facilitate Collaborative (Academic-Industrial) Drug Development, Garret A. Fitzgerald
Marquette Intellectual Property Law Review
None.
Ip Policy Forum: New Business Models To Find Cures And Lower Healthcare Costs: A Role For Drug Repurposing, Bruce Bloom
Ip Policy Forum: New Business Models To Find Cures And Lower Healthcare Costs: A Role For Drug Repurposing, Bruce Bloom
Marquette Intellectual Property Law Review
None.
Ip Policy Forum: Repurposing & Collaborative Drug Development For Rare Diseases, Ramaiah Muthyala
Ip Policy Forum: Repurposing & Collaborative Drug Development For Rare Diseases, Ramaiah Muthyala
Marquette Intellectual Property Law Review
None.
Ip Policy Forum: The Future Of Clinical Trials: More Transparency And Pharmacogenomics, Harsha K. Rajasimha
Ip Policy Forum: The Future Of Clinical Trials: More Transparency And Pharmacogenomics, Harsha K. Rajasimha
Marquette Intellectual Property Law Review
None.
Ip Policy Forum: Implications Of Genomics Advances For Drug Discovery, Clinical Therapies, & Rare Disease Research, John R. Raymond
Ip Policy Forum: Implications Of Genomics Advances For Drug Discovery, Clinical Therapies, & Rare Disease Research, John R. Raymond
Marquette Intellectual Property Law Review
None.
Ip Policy Forum: Intellectual Property Rights (Ipr) In Collaborative Drug Development In The Eu: Helping A European Public-Private Partnership Deliver - The Need For A Flexible Approach To Ipr, Hugh Laverty, Magali Poinot
Ip Policy Forum: Intellectual Property Rights (Ipr) In Collaborative Drug Development In The Eu: Helping A European Public-Private Partnership Deliver - The Need For A Flexible Approach To Ipr, Hugh Laverty, Magali Poinot
Marquette Intellectual Property Law Review
None.
Ip Policy Forum: Foreword From The Editors
Ip Policy Forum: Foreword From The Editors
Marquette Intellectual Property Law Review
None.
Functional Signs And Decanters Of Wine: How Trade Dress Protection Unconstitutionally Extends Expired Design Patents, Tyler Jackson
Functional Signs And Decanters Of Wine: How Trade Dress Protection Unconstitutionally Extends Expired Design Patents, Tyler Jackson
Marquette Intellectual Property Law Review
None.
Searching For An Out: Rojadirecta, Myvidster, And The Knowledge Components Of The Information Location Tool Exemption Of § 512(D), Kevin J. Wleklinski
Searching For An Out: Rojadirecta, Myvidster, And The Knowledge Components Of The Information Location Tool Exemption Of § 512(D), Kevin J. Wleklinski
Marquette Intellectual Property Law Review
None.
One View Of Compulsory Licensing: Comparative Perspectives From India And Canada, Padmanabha Ramanujam, Yugank Goyal
One View Of Compulsory Licensing: Comparative Perspectives From India And Canada, Padmanabha Ramanujam, Yugank Goyal
Marquette Intellectual Property Law Review
None.
Patent Club Convergence Among Nations, Daniel Benoliel
Patent Club Convergence Among Nations, Daniel Benoliel
Marquette Intellectual Property Law Review
The article uncovers profound empirical and conceptual shortcomings concerning the "one-size-fits-all" innovation and intellectual property-related policies used internationally. These policies surely are funneled by the World Trade Organization (WTO) and the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) or the World Intellectual Property Organization’s (WIPO) archetypical Development Agenda. The article offers a novel delineation of these policies vis-à-vis distinct country groups or “convergence clubs.”
In so doing, the article offers a unique statistical model carrying out hierarchal cluster analyses for sixty-six innovating countries twice during the 1996–2011 time series period. The model detects country groups that are …
Patent Markets: An Opportunity For Technology Diffusion And Frand Licensing?, Stéphanie Chuffart-Finsterwald
Patent Markets: An Opportunity For Technology Diffusion And Frand Licensing?, Stéphanie Chuffart-Finsterwald
Marquette Intellectual Property Law Review
None.
Indigenous Peoples' Rights At The Intersection Of Human Rights And Intellectual Property Rights, Chidi Oguamanam
Indigenous Peoples' Rights At The Intersection Of Human Rights And Intellectual Property Rights, Chidi Oguamanam
Marquette Intellectual Property Law Review
None.
Likelihood Of Destruction - Restructuring The Trademark Dilution By Blurring Factors In The Trademark Dilution Revision Act Of 2006, Derek A. Hawkins
Likelihood Of Destruction - Restructuring The Trademark Dilution By Blurring Factors In The Trademark Dilution Revision Act Of 2006, Derek A. Hawkins
Marquette Intellectual Property Law Review
None.